EPS15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.419900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.811600E-02
Normal-vs-Stage2
3.175700E-02
Normal-vs-Stage3
1.501170E-01
Normal-vs-Stage4
4.219200E-01
Stage1-vs-Stage2
6.133400E-01
Stage1-vs-Stage3
1.676370E-01
Stage1-vs-Stage4
1.181240E-01
Stage2-vs-Stage3
1.150410E-01
Stage2-vs-Stage4
2.752800E-01
Stage3-vs-Stage4
8.862300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.291700E-02
Normal-vs-AfricanAmerican
3.176400E-01
Normal-vs-Asian
2.339600E-02
Caucasian-vs-AfricanAmerican
5.046600E-01
Caucasian-vs-Asian
2.760600E-01
AfricanAmerican-vs-Asian
2.501000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.739720E-02
Normal-vs-Female
4.743900E-02
Male-vs-Female
2.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.703800E-01
Normal-vs-Age(41-60Yrs)
7.670400E-02
Normal-vs-Age(61-80Yrs)
2.055800E-02
Normal-vs-Age(81-100Yrs)
1.998150E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.534600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.730400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.537600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.959870E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.251700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.307800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.186100E-02
Normal-vs-Daily Drinker
8.679400E-03
Normal-vs-Weekly Drinker
1.925820E-02
Normal-vs-Occasional Drinker
3.584200E-02
Normal-vs-Social Drinker
1.962240E-01
Non Drinker-vs-Daily Drinker
5.210000E-01
Non Drinker-vs-Weekly Drinker
4.865400E-01
Non Drinker-vs-Occasional Drinker
3.201800E-01
Non Drinker-vs-Social Drinker
3.259000E-01
Daily Drinker-vs-Weekly Drinker
8.722800E-01
Daily Drinker-vs-Occasional Drinker
9.723800E-02
Daily Drinker-vs-Social Drinker
1.570960E-01
Weekly Drinker-vs-Occasional Drinker
1.073370E-01
Weekly Drinker-vs-Social Drinker
1.937030E-01
Occasional Drinker-vs-Social Drinker
8.406600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.737010E-01
Normal-vs-Grade 2
2.149600E-02
Normal-vs-Grade 3
2.431800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.016800E-01
Grade 1-vs-Grade 3
4.054600E-01
Grade 1-vs-Grade 4
1.737010E-01
Grade 2-vs-Grade 3
5.367200E-01
Grade 2-vs-Grade 4
2.149600E-02
Grade 3-vs-Grade 4
2.431800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.361800E-02
Normal-vs-NonDiabetic
9.140300E-03
Diabetic-vs-NonDiabetic
7.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.261930E-02
Normal-vs-NoPancreatitis
1.494250E-02
Pancreatitis-vs-NoPancreatitis
3.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.726400E-02
Normal-vs-N1
2.452300E-02
N0-vs-N1
8.719000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.503000E-01
Normal-vs-TP53-NonMutant
1.641960E-01
TP53-Mutant-vs-TP53-NonMutant
1.103370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
